Literature DB >> 24052195

Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Blaire E Burman1, Nizar A Mukhtar, Brian C Toy, Tung T Nguyen, Alice Hm Chen, Albert Yu, Peter Berman, Hali Hammer, Daniel Chan, Charles E McCulloch, Mandana Khalili.   

Abstract

BACKGROUND: Hepatitis B (HBV) is prevalent in certain US populations and regular HBV disease monitoring is critical to reducing associated morbidity and mortality. Adherence to established HBV monitoring guidelines among primary care providers is unknown. AIMS: The purpose of this study was to evaluate HBV disease monitoring patterns and factors associated with adherence to HBV management guidelines in the primary care setting.
METHODS: Primary providers within the San Francisco safety net healthcare system were surveyed for HBV management practices, knowledge, attitudes, and barriers to HBV care. Medical records from 1,727 HBV-infected patients were also reviewed retrospectively.
RESULTS: Of 148 (45 %) responding providers, 79 % reported ALT and 44 % reported HBV viral load testing every 6-12 months. Most providers were knowledgeable about HBV but 43 % were unfamiliar with HBV management guidelines. Patient characteristics included: mean age 51 years, 54 % male and 67 % Asian. Within the past year, 75 % had ALT, 24 % viral load, 21 % HBeAg tested, and 40 % of at-risk patients had abdominal imaging for HCC. Provider familiarity with guidelines (OR 1.02, 95 % CI 1.00-1.03), Asian patient race (OR 4.18, 95 % CI 2.40-7.27), and patient age were associated with recommended HBV monitoring. Provider HBV knowledge and attitudes were positively associated, while provider age and perceived barriers were negatively associated with HCC surveillance.
CONCLUSIONS: Comprehensive HBV disease monitoring including HCC screening with imaging were suboptimal. While familiarity with AASLD guidelines and patient factors were associated with HBV monitoring, only provider and practice factors were associated with HCC surveillance. These findings highlight the importance of targeted provider education to improve HBV care.

Entities:  

Mesh:

Year:  2013        PMID: 24052195      PMCID: PMC3947196          DOI: 10.1007/s10620-013-2870-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites.

Authors:  Sabrina T Wong; Ginny Gildengorin; Tung Nguyen; Jeremiah Mock
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

2.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 3.  Long-term outcomes in hepatitis B: the REVEAL-HBV study.

Authors:  Chien-Jen Chen; Uchenna H Iloeje; Hwai-I Yang
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

4.  Health care access and utilization among US-born and foreign-born Asian Americans.

Authors:  Jiali Ye; Dominic Mack; Yvonne Fry-Johnson; Katrina Parker
Journal:  J Immigr Minor Health       Date:  2012-10

5.  Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-05-12       Impact factor: 17.586

6.  Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Anthony E Fiore; Annemarie Wasley; Beth P Bell
Journal:  MMWR Recomm Rep       Date:  2006-05-19

7.  Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients.

Authors:  Cindy J Lai; Tung T Nguyen; Jimmy Hwang; Susan L Stewart; Anson Kwan; Stephen J McPhee
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

8.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

Review 9.  Economics of chronic hepatitis B and hepatitis C.

Authors:  Arathi Rajendra; John B Wong
Journal:  J Hepatol       Date:  2007-07-30       Impact factor: 25.083

10.  Factors influencing physicians' screening behavior for liver cancer among high-risk patients.

Authors:  Tung T Nguyen; Ginny Gildengorin; Amy Truong; Stephen J McPhee
Journal:  J Gen Intern Med       Date:  2007-04       Impact factor: 5.128

View more
  17 in total

Review 1.  Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States.

Authors:  Simona Ispas; Samuel So; Mehlika Toy
Journal:  J Community Health       Date:  2019-06

2.  Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment.

Authors:  Mehlika Toy; Utkan Demirci; Samuel So
Journal:  Hepat Oncol       Date:  2014-09-09

3.  Characteristics and management of patients with chronic hepatitis B in an integrated care setting.

Authors:  Monika Sarkar; Valentina A Shvachko; Joanna B Ready; Mary Pat Pauly; Norah A Terrault; Marion G Peters; M Michele Manos
Journal:  Dig Dis Sci       Date:  2014-04-12       Impact factor: 3.199

4.  Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York City.

Authors:  S Fitzgerald; J Chao; Y Feferman; P Perumalswami; U Sarpel
Journal:  J Racial Ethn Health Disparities       Date:  2016-10-28

5.  Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.

Authors:  Nizar A Mukhtar; Priya Kathpalia; Joan F Hilton; Gene Lau; Albert Yu; Kevin Grumbach; Tung T Nguyen; Daniel Chan; Mandana Khalili
Journal:  J Clin Gastroenterol       Date:  2017-08       Impact factor: 3.062

6.  Peripartum Maternal Hepatitis B Care in a US Nationwide Data Set.

Authors:  Matthew S Chang; J Frank Wharam; Fang Zhang; Robert F LeCates; Emma Morton-Eggleston; Ruth E Tuomala; Anna E Rutherford; Muthoka L Mutinga; Karin L Andersson; Robert S Brown; Chinweike Ukomadu; Emily Oken
Journal:  J Clin Gastroenterol       Date:  2019 Nov/Dec       Impact factor: 3.062

7.  Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.

Authors:  Bevin Hearn; Rachel Chasan; Kian Bichoupan; Maria Suprun; Emilia Bagiella; Douglas T Dieterich; Ponni Perumalswami; Andrea D Branch; Shirish Huprikar
Journal:  Clin Infect Dis       Date:  2015-08-03       Impact factor: 9.079

8.  Postpartum care for mothers diagnosed with hepatitis B during pregnancy.

Authors:  Matthew S Chang; Ruth Tuomala; Anna E Rutherford; Muthoka L Mutinga; Karin L Andersson; Blaire E Burman; Robert S Brown; Emily Oken; Chinweike Ukomadu
Journal:  Am J Obstet Gynecol       Date:  2014-09-30       Impact factor: 8.661

9.  Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan.

Authors:  Qurat-Ul-Ain Hafeez; Amna S Butt; Furqaan Ahmed
Journal:  J Clin Exp Hepatol       Date:  2018-02-10

10.  Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.

Authors:  Nizar A Mukhtar; Donna M Evon; Colina Yim; Anna S Lok; Nadra Lisha; Mauricio Lisker-Melman; Mohamed Hassan; Harry L A Janssen; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2020-04-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.